Revive Therapeutics Ltd. (CSE: RVV)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Sep 23, 2024, 4:00 PM EDT
Revive Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1.05 | 2.09 | 3.92 | 16.6 | 1.38 | 0.48 | Upgrade
|
| Short-Term Investments | - | - | - | - | 0.1 | - | Upgrade
|
| Cash & Short-Term Investments | 1.05 | 2.09 | 3.92 | 16.6 | 1.48 | 0.48 | Upgrade
|
| Cash Growth | -60.48% | -46.69% | -76.41% | 1020.48% | 211.74% | -55.19% | Upgrade
|
| Accounts Receivable | 0.05 | 0.14 | 0.11 | 0.09 | 0.08 | - | Upgrade
|
| Other Receivables | 0.07 | 0.02 | 0.08 | 0.03 | 0.1 | - | Upgrade
|
| Receivables | 0.12 | 0.16 | 0.19 | 0.13 | 0.18 | - | Upgrade
|
| Prepaid Expenses | 0.08 | 0.06 | 0.06 | 0.07 | 0.5 | 0.05 | Upgrade
|
| Restricted Cash | 0.05 | 0.05 | - | - | - | - | Upgrade
|
| Total Current Assets | 1.29 | 2.35 | 4.16 | 16.79 | 2.16 | 0.53 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Long-Term Investments | 0.13 | 0.16 | 0.25 | 0.25 | 0.25 | 0.75 | Upgrade
|
| Other Intangible Assets | 11.72 | 11.72 | 12.5 | 12.5 | 5.5 | - | Upgrade
|
| Long-Term Accounts Receivable | - | 0.01 | 0.15 | 0.26 | 0.35 | - | Upgrade
|
| Total Assets | 13.14 | 14.25 | 17.07 | 29.81 | 8.26 | 1.28 | Upgrade
|
| Accounts Payable | 2.54 | 2.66 | 3.92 | 0.44 | 0.21 | 0.2 | Upgrade
|
| Accrued Expenses | 0.64 | 0.64 | 0.14 | 0.07 | 0.09 | 0.12 | Upgrade
|
| Current Portion of Leases | 0.06 | 0.13 | 0.11 | 0.09 | 0.07 | - | Upgrade
|
| Total Current Liabilities | 3.25 | 3.44 | 4.17 | 0.6 | 0.37 | 0.32 | Upgrade
|
| Long-Term Debt | - | 0.06 | 0.06 | 0.06 | 0.04 | - | Upgrade
|
| Long-Term Leases | - | 0.03 | 0.16 | 0.27 | 0.36 | - | Upgrade
|
| Other Long-Term Liabilities | 0.08 | 0.08 | 0.08 | 0.07 | 0.06 | - | Upgrade
|
| Total Liabilities | 3.33 | 3.6 | 4.46 | 1 | 0.83 | 0.32 | Upgrade
|
| Common Stock | 47.5 | 45.98 | 43.11 | 42.43 | 19.13 | 9.35 | Upgrade
|
| Additional Paid-In Capital | 23.51 | 12.66 | 12.4 | 11.39 | 3.22 | 2.12 | Upgrade
|
| Retained Earnings | -63.6 | -60.57 | -54.25 | -36.44 | -16.32 | -10.94 | Upgrade
|
| Comprensive Income & Other | 2.41 | 12.58 | 11.34 | 11.43 | 1.4 | 0.43 | Upgrade
|
| Shareholders' Equity | 9.82 | 10.65 | 12.6 | 28.81 | 7.43 | 0.96 | Upgrade
|
| Total Liabilities & Equity | 13.14 | 14.25 | 17.07 | 29.81 | 8.26 | 1.28 | Upgrade
|
| Total Debt | 0.06 | 0.22 | 0.33 | 0.42 | 0.47 | - | Upgrade
|
| Net Cash (Debt) | 0.99 | 1.87 | 3.59 | 16.18 | 1.02 | 0.48 | Upgrade
|
| Net Cash Growth | -58.95% | -47.94% | -77.83% | 1493.48% | 113.71% | -55.19% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.01 | 0.01 | 0.06 | 0.01 | 0.01 | Upgrade
|
| Filing Date Shares Outstanding | 418.56 | 357.65 | 321.13 | 317.96 | 199.89 | 72.41 | Upgrade
|
| Total Common Shares Outstanding | 418.56 | 357.65 | 321.42 | 317.96 | 199.89 | 72.41 | Upgrade
|
| Working Capital | -1.95 | -1.08 | -0 | 16.2 | 1.79 | 0.21 | Upgrade
|
| Book Value Per Share | 0.02 | 0.03 | 0.04 | 0.09 | 0.04 | 0.01 | Upgrade
|
| Tangible Book Value | -1.91 | -1.07 | 0.1 | 16.31 | 1.93 | 0.96 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | -0.00 | 0.00 | 0.05 | 0.01 | 0.01 | Upgrade
|
| Machinery | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.